PhaseBio shares fall despite positive late-stage study results for lead drug candidate
November 15, 2021 at 13:24 PM EST
Shares were down 8% in early afternoon trading on Monday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|